Background: The ion channel TRPV1 is mainly expressed in small diameter dorsal root ganglion (DRG) neurons, which are involved in the sensation of acute noxious thermal and chemical stimuli. Direct modifications of the channel by diverse signalling events have been intensively investigated, but little is known about the composition of modulating macromolecular TRPV1 signalling complexes. Here, we hypothesize that the novel adaptor protein ankyrin-rich membrane spanning protein/kinase D interacting substrate (ARMS) interacts with TRPV1 and modulates its function in rodent DRG neurons. Methods: We used immunohistochemistry, electrophysiology, microfluorimetry and immunoprecipitation experiments to investigate TRPV1 and ARMS interactions in DRG neurons and transfected cells. Results: We found that TRPV1 and ARMS are co-expressed in a subpopulation of DRG neurons. ARMS sensitizes TRPV1 towards capsaicin in transfected HEK 293 cells and in mouse DRG neurons in a PKA-dependent manner. Using a combination of functional imaging and immunocytochemistry, we show that the magnitude of the capsaicin response in DRG neurons depends not only on TRPV1 expression, but on the co-expression of ARMS alongside TRPV1. Conclusion: These data indicate that ARMS is an important component of the signalling complex regulating the sensitivity of TRPV1. Significance: The study identifies ARMS as an important component of the signalling complex regulating the sensitivity of excitatory ion channels (TRPV1) in peripheral sensory neurons (DRG neurons) and transfected cells.
Introduction
The transient receptor potential vanilloid 1 (TRPV1) is predominantly expressed in nociceptive dorsal root ganglion (DRG) neurons. It is a key player in the sensation of painful stimuli, in the generation of thermal hyperalgesia during inflammation, and it became a major target in the preclinical development of pain therapeutics (Caterina et al., 1997 (Caterina et al., , 2000 . TRPV1 is modulated by opioid receptor/cAMP interactions, phospholipases, phospholipids, kinases and phosphatases (Tominaga and Tominaga, 2005; Endres-Becker et al., 2007; Spahn et al., 2013) .
Little is known about the intracellular TRPV1 signalling complexes in sensory neurons. A first discovery was the A-kinase anchoring protein 150 (AKAP150 in rodents, AKAP79 in humans) which functions as a scaffold for protein kinase A (PKA), facilitating the association of the enzyme with its substrates at distinct subcellular loci (Beene and Scott, 2007) . This complex is involved in PKA-and PKCe-induced TRPV1 sensitization in DRG neurons (Rathee et al., 2002; Distler et al., 2003; Jeske et al., 2008 Jeske et al., , 2009 Schnizler et al., 2008) . Recently, it was shown that the RIIb subunit of the PKA II isoform is predominantly expressed in nociceptors and can be used as a marker of these neurons (Isensee et al., 2014a) . In addition, a direct non-canonical interaction of TRPV1 and the GABAB1 receptor was identified (Hanack et al., 2015) .
Another potential interaction partner of TRPV1 is the adaptor protein ankyrin-rich membrane spanning protein/kinase D interacting substrate (ARMS). ARMS was previously identified as a large adaptor protein featuring numerous protein-protein interaction motifs, specifically expressed in the nervous system (Iglesias et al., 2000; Kong et al., 2001) . So far, ARMS has been shown to be involved in neurotrophic signalling, neuronal development, synaptic transmission and in the control of neurotransmitter release [reviewed in (Neubrand et al., 2012) ]. It was also identified as an essential interaction partner of the nerve growth factor receptor TrkA (Kong et al., 2001 ). Recently we showed ARMS mRNA to be coexpressed in TRPV1-positive nociceptive neurons (Isensee et al., 2014b) . Although ARMS was initially identified in DRG neurons, most functional studies on ARMS focused on central neurons or used heterologous expression systems (Kong et al., 2001 ). Here, we explore the functional role of ARMS in the context of TRPV1 signalling in DRG neurons and transfected cells.
Materials and methods

Mice and preparation of tissues
Experimental procedures were approved by the state animal care and use committee (Landesamt f€ ur Arbeitsschutz, Gesundheit und Technische Sicherheit Berlin). Male C57BL/6J mice (Mus musculus) were obtained from the animal housing facility of the Charit e (FEM; Forschungseinrichtung f€ ur experimentelle Medizin). For cryosectioning mice were sacrificed using an overdose of isoflurane (Piramal Critical Care, Bethlehem, NY, USA) and perfused with 0.1 mol/L phosphate buffer (PB) followed by fixation with 4% paraformaldehyde (PFA) in PB. Spinal cord (SC) and DRG were removed and postfixed for 20 min in 4% PFA/PB. The tissue was cryoprotected in 30% sucrose in PB overnight at 4°C and mounted with Neg50 (Thermo Fisher Scientific, Hennigsdorf, Germany). Twelve lm thick sections were cut using a Microm HM560 crystat (Microm). Sections were transferred to poly-L-lysine coated glass slides (Thermo Fisher) and stored at À20°C until staining procedures.
Primary cell culture
Dorsal root ganglion neurons were prepared as described previously (Endres-Becker et al., 2007; Bessac et al., 2009) . A brief description is provided in the Supporting Information Appendix S1.
Cell culture and heterologous expression
Human embryonic kidney (HEK) 293 cells (DSMZ) were maintained at 37°C, 5% CO 2 in DMEM (Biochrom, Berlin, Germany) containing 10% foetal bovine serum and 1% penicillin/streptomycin. They were passaged 1:2-1:5 every second to third day depending on the confluence. The plating and transfection procedure for the different experiments is described in the Supporting Information Appendix S2.
Patch clamp recordings
Whole-cell voltage clamp recordings were performed in TRPV1-or TRPV1 and ARMS-expressing HEK 293 cells with or without pretreatment of 10 lmol/L: myristoylated PKA inhibitor fragment 14-22 (myr-PKI; Sigma Aldrich, Taufkirchen, Germany) for 30 min at À60 mV holding potential with an EPC-10 patch clamp amplifier and PULSE software (HEKA Elektronik, Lambrecht, Germany) as described previously (Endres-Becker et al., 2007; Spahn et al., 2013 Spahn et al., , 2014 . Experiments were performed 16-24 h after transfection and the TRPV1 channel was activated by the addition of 50 nmol/L capsaicin.
Ratiometric [Ca
2+ ] i measurements
Eighteen to twenty-our hours post transfection HEK 293 cells were loaded with the fluorescent calcium indicator dye Fura 2-AM (2 lmol/L) supplied with 0.02% pluronic F-127 (Invitrogen, Karlsruhe, Germany) for 20 min. TRPV1 was activated by capsaicin (1 pmol/L, 100 pmol/L, 500 pmol/L, 1 nmol/L, 20 nmol/L, 100 nmol/L, 200 nmol/L, 1 lmol/L, 3 lmol/L) contained in calcium imaging buffer (140 mmol/L NaCl, 4 mmol/L KCl, 2 mmol/L CaCl 2 , 1 mmol/L MgCl 2 , 4.55 mmol/L NaOH, 5 mmol/L Glucose, and 10 mmol/L HEPES, adjusted to pH 7.4 with NaOH) in the presence or absence of the unspecific PKA inhibitor H89 (N-[2-(p-Bromocinnamylamino) ethyl]-5-isoquinolinesulfonamide dihydrochloride; Sigma-Aldrich), the specific PKA inhibitor myr-PKI (Rathee et al., 2002 ) (Sigma-Aldrich) or 1 lmol/L of the PKC inhibitor GF 109203X (Sigma Aldrich). The cells were treated with H89 or GF 109203X 20 min and with myr-PKI 30 min prior to the experiment. After 20 s baseline determination, fluorescent signals were recorded for 100 s. Images were acquired as described previously (Spahn et al., 2013) . Viability was tested using a 3 lmol/L capsaicin stimulus at the end of each measurement. Cells were included in the analyses, if the Fura ratio at baseline did not fluctuate more than 10% and if the cells responded to 3 lmol/ L capsaicin with a Fura ratio (F340/380) > 1.
For the combined calcium imaging/immunocytochemistry experiments (see Appendix S3), DRG neurons were loaded with 0.25 lg Fura 2-AM to 80 lL cell culture wells and incubated at 37°C and 5% CO 2 . After 40 min, the wells were washed twice for 10 min with warmed media, supplemented with Neurobasal A for neurons. Image capturing was performed after alternating excitations (340 and 380 nm) at 510 nm in the Cellomics ArrayScan High Content Screening platform. Stimulation of cultures was handled by an integrated pipetting robot. A maximum of eight wells was measured in a row to prevent Fura intoxification.
Immunohistochemistry
Dorsal root ganglion sections of mice were thawed, rehydrated in PBS, permeabilized in PBS with 0.2% Triton X-100 (PBT) for 10 min and blocked for 1 h in blocking buffer (PBT, 1% BSA, 5% serum of the host animal of the second antibody). For double or triple staining, the Zenon antibody labelling technology (Invitrogen) was used, according to the manufacturer's instructions. This technique avoids cross-reactivity, if the primary antibodies were raised in the same host. The stained sections were analysed using confocal laser scanning microscopy (LSM 510meta; Carl Zeiss, Jena, Germany) and quantified using ImageJ. Further information is provided in Appendix S4.
Immunoprecipitation and western blot analysis
Samples of transfected HEK 293 cells, DRG neurons or SC were lysed in a buffer containing 150 mmol/L NaCl, 50 mmol/L TRIS, 10 mmol/L HEPES, 1% Triton X-100, 19 Protease Inhibitor Mix (Complete protease inhibitor cocktail; Roche Diagnostics, Rotkreuz, Switzerland) at pH 7.8. Nuclei and debris were removed by centrifugation at 1000 g for 5 min and protein concentrations were measured by the BCA assay (Thermo Fisher Scientific, Waltham, MA, USA). Equal protein concentrations (in lg protein ml-1 buffer) of the resulting cell homogenates were subjected to immunoprecipitation (Appendix S5). Western blot analysis was performed as described previously (Busch-Dienstfertig et al., 2012 ) (Appendix S5).
For the interaction analysis experiments using cAMP-analog-agarose (Hanke et al., 2011) , cells were treated as described in Appendix S5.
Radioligand binding assay
Forty-eight hours post transfection, TRPV1-and TRPV1/ARMS-expressing HEK 293 were prepared using either the plasma membrane protein extraction kit (ab65400, Abcam, Milton, Great Britain) to separate total (including plasma and organelle membrane proteins, TMF) and plasma membrane fractions (PMF) according to the manufacturer's instructions or membrane preparations according to a modified protocol for transfected HEK 293 cells (Szallasi et al., 1992 (Szallasi et al., , 1999 .
The TRPV1 expression was determined using the radioactively labelled TRPV1 agonist [ 3 H] resiniferatoxin (RTX). The experiment was carried out according to a modified protocol (Szallasi et al., 1992 (Szallasi et al., , 1999 . Briefly, appropriate concentrations of membranes (100-200 lg) were prepared and incubated in assay buffer (50 mmol/L Trizma, 0.25 mg/mL bovine serum albumin, pH 7.4) with 1.1 nmol/L [ 3 H] RTX (39.2 Ci/ mmol) (Perkin Elmer, Waltham, MA, USA) in the absence or presence of 10 lmol/L unlabelled RTX to assess affinity by displacement (Spahn et al., 2013) .
Statistics
Data are presented as means AE SEM. Statistical significance is denoted as p < 0.05 (*), p < 0.01 (**) and p < 0.001 (***). Statistical analysis was performed using 1-way ANOVA with Bonferroni's post test, Kruskal-Wallis test with Dunn's post test, or Mann-Whitney U test in co-expression studies. For patch clamp and calcium imaging experiments, unpaired t-test, Mann-Whitney U test and 2-way ANOVA with Bonferroni's post test were used. Dose-response curves were fitted with the Hill equation. All tests were performed using Prism 5 (GraphPad, San Diego, CA, USA).
Results
Co-expression of TRPV1 and ARMS in DRG neurons
Immunohistochemistry revealed four different subpopulations in mouse DRG neurons, namely cells expressing TRPV1 but not ARMS (TRPV1+/ARMSÀ) (5.16% of the investigated cells; 340.2 AE 9.4 lm The average size of all investigated neurons (n = 13,349 of six mice) was 530.9 AE 3.8 lm². Of these cells, 35.49% were TRPV1-positive with a mean cell size of 396.1 AE 4.27 lm². 79.24% of the cells were ARMS-positive. The size of this subpopulation was 546.6 AE 4.33 lm² (Fig. 1D ). Fig. 1E shows the size distribution of all TRPV1-positive cells, cells positive for TRPV1 but negative for ARMS, and positive for both TRPV1 and ARMS. Cells expressing only TRPV1 (blue bars) were smaller compared to those expressing both proteins (red bars). In Fig. 1F the ratio of subpopulations is visualized as Venn-diagram.
Functional and physical interaction of TRPV1, ARMS and PKA in HEK 293 cells and DRG neurons
To investigate possible functional interaction of TRPV1 and ARMS, we performed calcium imaging experiments. TRPV1/ARMS-expressing HEK 293 cells showed stronger calcium increase upon stimulation with a very low capsaicin concentration (1 nmol/L) than cells expressing TRPV1 alone (Fig. 2A, C and F) . At the end of each measurement, all cells were stimulated with 3 lmol/L capsaicin and showed no significant differences between the groups ( Fig. 2A , D and G). We further investigated the role of kinases in mediating increased capsaicin-induced TRPV1 activity in cells expressing TRPV1 and ARMS compared to cells only expressing TRPV1. Fig. 4A shows 1 nmol/L capsaicin-induced maximum changes of F340/380. The significantly stronger calcium influx was abolished by pretreating the cells with H89 and the PKC inhibitor GF 109203X. In addition, inhibition of PKC resulted in significantly weaker calcium influx in both expression groups compared to untreated cells, possibly due to more general effects of PKC inhibition in this context. Since H89 is an unspecific PKA inhibitor we used myr-PKI, which was shown to be specific for PKA. In calcium imaging and patch clamp experiments, pretreatment with 10 lmol/L myr-PKI for 30 min reversed the increased capsaicin-induced TRPV1 activity in TRPV1/ARMS co-expressing cells compared to cells only expressing TRPV1 (Fig. 4A and B) .
To investigate whether the increased TRPV1 activity is due to a physical interaction between the proteins, TRPV1 and ARMS plasmids were cotransfected into HEK293 cells. Co-immunoprecipitation experiments were performed with an antibody directed against ARMS (Fig. 5A, left with antibodies against TRPV1 or ARMS, respectively. ARMS co-precipitated with TRPV1 in this heterologous system. A clear band in the western blot marked the precipitated TRPV1 at about 120 kDa (Fig. 5A , left panel, lane TRPV1/ARMS), suggesting an interaction between tagged full length TRPV1 and full length ARMS. In Fig. 5B the co-immunoprecipitation was performed using anti-TRPV1 with or without control peptide for TRPV1 and the western blot using anti-ARMS antibody. A band for ARMS (at~200 kDa) was only detectable in samples without the control peptide ( and 3, respectively). A similar co-immunoprecipitation experiment was conducted with tissue of DRG neurons suggesting that TRPV1 and ARMS interact in native tissue as well ( Fig. 5A and B, right panel) . The calcium imaging experiments revealed that components of PKA might be involved in these processes. For that reason physical interaction analysis of ARMS, TRPV1 and the PKA holoenzyme were carried out. Transfected HEK293 cells expressing ARMS, TRPV1 or ARMS/TRPV1 were lysed and endogenous PKA holoenzyme was co-precipitated with the cAMP derivative, Rp-8-AEA-cAMPS, coupled to agarose beads. Rp-8-AEA-cAMPS is a cAMPanalog that couples regulatory subunits of PKA (de Wit et al., 1984) . However, in contrast to cAMP, it prevents the dissociation of the PKA holoenzyme leading to a stable and inactive PKA heterotetramer. This way PKA-holoenzyme associated protein complexes can be precipitated. Elution of precipitated PKA holoenzymes and their associated proteins was carried out by boiling of Rp-cAMPS-agarose beads. SDS-PAGE was applied and proteins were transferred to a nitrocellulose membrane. Afterwards, western blot analysis with antibodies against proteins of interest (ARMS, TRPV1, C -subunit of PKA, pan RIsubunit and RIIb of PKA) were used to identify the respective protein-protein interactions. Therefore, two antibodies from different species were used simultaneously.
ARMS (~190 kDa, green) and TRPV1 (~90 kDa, red) of cells expressing ARMS, TRPV1 and TRPV1/ ARMS, respectively, could be detected in the PKA precipitated samples. Therefore, ARMS, TRPV1 and ARMS/TRPV1 were able to bind the PKA holoenzyme, giving support for the co-immunoprecipitation experiments shown in Fig. 5A and B. Untransfected (nt) cells yielded no fluorescence signal after incubation with anti-ARMS and anti-TRPV1 antibodies, demonstrating the specificity of these antibodies. Input sample of ARMS/TRPV1 coexpressing cells served as expression control for TRPV1 and ARMS. ARMS could not be detected, probably due to a too low concentration in total cell lysate. Purified recombinant proteins of PKA isoforms (RIa, RIb, RIIa, RIIb/Ca) were loaded to the SDS-gel as control for immunodetection of PKA subunits. They were not detected by anti-ARMS and anti-TRPV1 antibodies. After removal of the anti-TRPV1 and anti-ARMS antibodies, the membrane was probed with antibodies against PKA isoforms (Fig. 5D) . Using a pan-RI antibody, RIa (MW of~50 kDa, green) could be detected in cell lysates including that of untransfected cells. RIb subunits could not be detected using the pan-RI antibody probably due to low expression levels in transfected HEK293 cells. In the input sample, R-subunits could not be detected by pan-RI antibody probably because of the antibody's detection limit. Purified RIa and RIb subunits were detected as well (~50 kDa, green) serving as positive control for the specificity of the pan-RI antibody. To demonstrate the functionality of Rp-8-AEA-cAMPS-agarose on PKA holoenzyme, an anti-C-subunit antibody was applied simultaneously. At a molecular weight of a 40 kDa, a signal of catalytic subunits in all elutions as well as purified Ca could be detected (red). Catalytic subunits were detected in the input sample of ARMS/TRPV1 transfected cells (Fig 5D) . After the removal of pan-RI and C-subunit antibodies, membrane was probed with a specific anti-RIIb antibody (Fig. S2) . RIIb was detected in all elutions (~50 kDa,-green) and in the positive control. Weak fluorescence signals (green) in some elutions (narrow below 50 kDa) and in RIa and RIb samples most likely result from incomplete removal of anti-pan-RI antibody since anti-pan-RI and anti-RIIb were raised in the same species.
To demonstrate the specificity of ARMS, TRPV1 and components of the PKA holoenzyme to the agarose beads, a control hydrolysed ethanolamine agarose was used. Fig. 5E shows no detection of ARMS and TRPV1 in the boiled control-agarose. TRPV1 gave fluorescence signal in the input sample (Input-TRPV1, 90 kDa, red), serving as expression control of single transfected cells. In the input-ARMS sample ARMS was below the detection limit of the anti-ARMS-antibody and could not be detected. Its expression was proven in the elution of ARMS transfected cells (Fig. 5C, 190 kDa, green) . Components of PKA did not stick to the control-agarose beads (Fig. 5F ). Therefore, only positive controls of RIb, RIa and Ca could be detected in this experiment. Weak fluorescence signals were present for Ca present in the input samples. RIIb also did not stick to control-agarose beads (Fig. S2B) . Only recombinant RIIb serving as specificity control was detected (50 kDa, green).
To relate the expression pattern of TRPV1 and ARMS to neuronal functionality, we combined calcium imaging and immunocytochemistry. After loading cultured mouse DRG neurons with Fura 2-AM, imaged cells were fixed and stained for TRPV1 and ARMS (Fig 6A-H) . In neurons expressing TRPV1 and ARMS separately (Fig. 6E-G) , the change in the Fura ratios after 50 nmol/L capsaicin of the neurons only expressing TRPV1 (Fig. 6H) was lower compared to the neurons co-expressing TRPV1 and ARMS (Fig. 6D) . The comparison of the maximum change in the Fura ratio after 50 nmol/L capsaicin between groups showed a strong tendency towards higher intensities in neurons co-expressing TRPV1 and ARMS. However, this difference was not statistically significant (Fig. 6I , Mann-Whitney U test, p > 0.05). Fig. 6J presents the change in the Fura ratio over time of all investigated neurons. At 60 s medium was added, at 80 s capsaicin and at 130 s 30 mmol/L KCl was administered to confirm cell viability. Of 458 investigated DRG neurons, <10% expressed only TRPV1, confirming the immunocytochemistry results.
TRPV1 expression in transfected HEK 293 cells
To address the question whether ARMS facilitates the expression of membrane-bound TRPV1 channels, we performed single point radioligand binding experiments in HEK 293 cells expressing TRPV1 alone or TRPV1 and ARMS. To separate plasma membrane-bound TRPV1 channels from TRPV1 expressed in total cell lysates (containing protein from both plasma membranes and organelle membranes), we used a plasma membrane protein extraction kit. The TMF of HEK 293 cells expressing TRPV1 and ARMS showed significantly increased [³H]-resiniferatoxin (RTX) (1.1 nmol/L) binding compared to cells only expressing TRPV1 (Fig. 7A , Mann-Whitney U test, *, p < 0.05, n = 7). The percentage of PMF-bound TRPV1 relative to the TMF was not different between TRPV1 and TRPV1/ARMS expressing cells (Fig. 7B , Mann-Whitney U test, p > 0.05, n = 6). Repetition of binding experiments without membrane separation showed that TRPV1 expression was significantly increased in the presence of ARMS compared to cells only expressing TRPV1. This effect was reversed by pretreating the cells with myr-PKI, indicating the involvement of PKA (Fig. 7C) . However, this experiment does not distinguish between total TRPV1 and plasma membrane TRPV1 expression. We assume that the increased total TRPV1 expression in TRPV1/ARMS co-expressing cells is based on a higher amount of TRPV1 stored in intracellular vesicles.
Co-expression of TRPV1 and ARMS with CGRP, IB4, NF200 and AKAP in DRG neurons
To classify the different subpopulations of TRPV1+/ ARMS+ and TRPV+/ARMSÀ expressing neurons, we co-stained the neurons for different markers. The results are presented in the Supporting Information Appendix S6, Fig. S1 and Table S2 .
Discussion
In this study, we provide evidence for ARMS expression in mouse DRG neurons at the protein level. Previous studies demonstrated prominent ARMS mRNA expression in the brain and other cells of neuronal origin, while heart tissue displayed lower expression levels (Iglesias et al., 2000) . Kong et al. showed ARMS DNA and mRNA expression in adult rat DRG neurons using Northern Blot and in situ hybridization (Kong et al., 2001 ). Other studies showed ARMS mRNA and protein expression in spleen and peripheral blood after airway allergen challenge (Li et al., 2013) . A functional role of ARMS was suggested by the investigation of Kidins220 (ARMS) knock-out mice. DRG subpopulations of these animals showed cell loss, proposing ARMS as a general survival factor during sensory neuron development (Cesca et al., 2011) . To our knowledge, our study is the first demonstrating ARMS expression in DRG neurons at the protein level, supporting those previous findings at the mRNA level.
Furthermore, our data suggest that ARMS represents a novel interaction partner of TRPV1 and PKA. Figure 5 Pull down experiments of TRPV1 and ARMS in transfected HEK 293 cells and native neuronal tissue. (A) Co-immunoprecipitation studies were performed in a heterologous (HEK293 cells, left panel) and native (DRG neurons, right panel) expression system. ARMS was precipitated using an antibody directed against ARMS followed by a subsequent detection of TRPV1 using a TRPV1 antibody (solid arrows). BSA-coated agarose beads served as a control. (B) Co-immunoprecipitation studies were performed in a heterologous (HEK293 cells, left panel) and native (DRG neurons, right panel) expression system. TRPV1 was precipitated using an antibody directed against TRPV1 followed by a subsequent detection of ARMS using an ARMS antibody (open arrows). BSA-coated agarose beads and control peptide against TRPV1 served as a control. (C) Pulldown experiments with Rp-8-AEA-cAMPS-agarose to pull down PKA holoenzyme of TRPV1 and ARMS expressing HEK 293 cells and control proteins of PKA isoforms. Afterwards SDS-PAGE analysis was applied with antibodies directed against TRPV1 (red at 90 kDa) and ARMS (green at 190 kDa). (D) Membrane of C was stripped to remove the first set of antibodies and incubated with antibodies against PKA subunits RI (green at 50 kDa) and C (red at 40 kDa). Both samples of transfected cells and control protein samples showed positive fluorescent signals RI and C-subunit of PKA. E) Pull down experiments with control agarose (PKA cannot bind to the coupled beads) of transfected HEK 293 cells and control proteins for PKA isoforms. Afterwards SDS-PAGE was applied and the membrane was treated with antibodies against TRPV1 (red at 90 kDa) and ARMS (green at 190 kDa). (F) Membrane of E was stripped to remove the first set of antibodies and incubated with antibodies against PKA subunits RI (green at 50 kDa) and C (red at 40 kDa). Only control protein samples showed fluorescent signals. (B, beads; FT, flow through; I, input IP; immunoprecipitation; nt, not transfected).
Our pull down experiments indicate that all three proteins interact physically in a signalling complex regulating TRPV1 sensitization. We detected functional interaction of ARMS and TRPV1 in mouse DRG neurons and in TRPV1/ARMS-expressing HEK 293 cells using immunohistochemistry, electrophysiology, microfluorimetry and a combination of microfluorimetry and immunocytochemistry. Cells expressing both proteins displayed enhanced response amplitudes to capsaicin in patch clamp and calcium imaging experiments compared to cells only expressing TRPV1. Using pull down experiments in transfected HEK 293 cells with Rp-8-AEA-cAMPSagarose, we found that PKA holoenzyme forms a complex with both TRPV1 and ARMS. Physical interaction of TRPV1 and PKA has already been demonstrated by others (Bhave et al., 2002) . We now show that ARMS and PKA form complexes too. To our knowledge this was shown for the first time. While PKA phosphorylation sites of TRPV1 are well known, further studies will have to be performed to identify PKA -ARMS and TRPV1 -ARMS interaction sites.
TRPV1 can be modulated by phosphorylation, transcriptional/translational regulation, interaction with phospholipids and protein-protein interactions. The latter are increasingly recognized, since TRPV1 has been shown to interact with modulatory proteins forming multi-protein signalling complexes with tubulins, the plasma membrane-associated protein Pirt, the scaffolding protein AKAP79/150, the Fasassociated factor, TRPV2, snapin, synaptotagmin IX, and GABAA receptor associated protein. These interactions influence the expression and activity of functional TRPV1 heteromers at the plasma membrane, the trafficking and insertion of TRPV1, the sensitivity to various stimuli and desensitization (Bhave et al., 2002; Morenilla-Palao et al., 2004; Zhang et al., 2005 Zhang et al., , 2008 Lukacs et al., 2007; Spahn et al., 2013 Spahn et al., , 2014 Kim et al., 2014) . For PKA it was shown that the complex of AKAP/PKA and TRPV1 is necessary for the insertion of functional tetramers into the plasma membrane (Vetter et al., 2008) . Expression studies showed that the majority of TRPV1 is cytosolic and needs to be inserted into the plasma membrane (Brandao et al., 2012) . A recent study identified that nearly 95% of TRPV1-positive DRG neurons co-express the regulatory subunit of the PKA, RIIb, another member of the TRPV1/AKAP signalosome (Isensee et al., 2014a) . The authors suggest that RIIb is a response predictor for capsaicin sensitivity and that the classical separation of DRG neurons into subpopulations based on morphological neuronal markers is insufficient. By demonstrating physical and functional interactions of TRPV1, ARMS and PKA, our data suggest that all three proteins are part of a signalling complex sensitizing TRPV1 towards capsaicin stimulation. Thus, future classifications of nociceptive neurons should take into account that excitatory ion channels such as TRPV1 are modulated by signalosomes consisting of proteins such as PKA and/or ARMS. Our calcium imaging and patch clamp experiments using the specific PKA inhibitor myr-PKI and the pull down experiments with Rp-8-AEA-cAMPS-agarose indicate that the cAMP/PKA pathway may play a role in the ARMS-mediated TRPV1 sensitization. TRPV1. This effect was abolished using the PKA inhibitor myr-PKI. Although the plasma membrane fraction of TRPV1/ARMS expressing cells was not increased compared cells only expressing TRPV1, we assume that the higher total TRPV1 expression is based on enhanced TRPV1 in intracellular vesicles. These stores can be rapidly inserted into the membrane leading to increased TRPV1 activity in calcium imaging and patch clamp experiments. This notion is supported by findings that PKA mediates the insertion of functional TRPV1 into the plasma membrane. Moreover, it was shown that phosphorylation events at TRPV1 sensitized TRPV1 to capsaicin (Jeske et al., 2008; Vetter et al., 2008) . Therefore, it is necessary to investigate phosphorylation events on TRPV1, but also on ARMS in future studies.
To our knowledge, a scaffolding effect of a protein regulating the activity of TRPV1 was only shown for AKAP79/150 and b-arrestin-2 so far. It was shown that AKAP 150 can arrange TRPV1, adenylyl cyclases, PKA and PKC to form a signalosome important for TRPV1 sensitization (Rathee et al., 2002; Jeske et al., 2008 Jeske et al., , 2009 Schnizler et al., 2008; Btesh et al., 2013; Efendiev et al., 2013) . On the other hand, TRPV1 and b-arrestin-2 association was shown to regulate TRPV1 desensitization (Por et al., 2012 (Por et al., , 2013 Rowan et al., 2014) .
Interestingly, we found that about 20% of TRPV1/ ARMS-expressing DRG neurons co-express AKAP 150 (Appendix S6 and Table S2 ). In line with a recent study, we found co-expression of TRPV1 and AKAP 150 predominantly in small sized neurons (Brandao et al., 2012) . However, the co-expression of TRPV1 and ARMS is not restricted to one population of nociceptors (either peptidergic, non-peptidergic or myelinated), since our co-expression studies using the neuronal markers CGRP, IB4 and NF200 showed expression of both proteins in all types of neurons (Fig. S1 , Table S2 ).
Numerous interaction partners were identified for ARMS in the last decade. A role of ARMS in the formation of receptor complexes was shown for the Trk receptor, and functional interactions with glutamate, Eph, VEGF receptors (VEGFRs), P-loop nucleotide phosphatases and ATP were identified. Due to the multiple binding domains of ARMS, this protein is a suitable candidate as a signalling platform [reviewed in (Neubrand et al., 2012) ]. ARMS regulates cytoskeletal remodelling, neuronal differentiation, neurotrophin signalling and interacts with cytoskeletal components such as tubulin (Arevalo et al., 2004; Higuero et al., 2010) . A very recent study identified ARMS as an interaction partner of brain voltagegated sodium channels, in which ARMS was able to modulate the activity of sodium channels. This study, in addition to ours, also underlines the ability of ARMS to act as signalling platform resulting in the modulation of ion channel activity (Cesca et al., 2015) .
In conclusion, our study showed co-expression of ARMS and TRPV1 protein in mouse DRG neurons. Furthermore, we identified a functional interaction of TRPV1 and ARMS, resulting in a PKA-dependent sensitization of TRPV1 to capsaicin. This emphasizes the role of signalling complex formation in the context of pain sensitization. With regard to the development of new analgesics, it might be necessary to investigate not only single proteins important for pain generation, transmission and sensitization, but also whole signalling complexes including several interaction partners.
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